1. Home
  2. TECH vs CINGW Comparison

TECH vs CINGW Comparison

Compare TECH & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • CINGW
  • Stock Information
  • Founded
  • TECH 1976
  • CINGW N/A
  • Country
  • TECH United States
  • CINGW United States
  • Employees
  • TECH N/A
  • CINGW 13
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • CINGW Biotechnology: Pharmaceutical Preparations
  • Sector
  • TECH Health Care
  • CINGW Health Care
  • Exchange
  • TECH Nasdaq
  • CINGW Nasdaq
  • Market Cap
  • TECH 8.0B
  • CINGW N/A
  • IPO Year
  • TECH 1989
  • CINGW 2021
  • Fundamental
  • Price
  • TECH $48.10
  • CINGW $0.04
  • Analyst Decision
  • TECH Buy
  • CINGW
  • Analyst Count
  • TECH 9
  • CINGW 0
  • Target Price
  • TECH $81.25
  • CINGW N/A
  • AVG Volume (30 Days)
  • TECH 2.2M
  • CINGW N/A
  • Earning Date
  • TECH 05-07-2025
  • CINGW N/A
  • Dividend Yield
  • TECH 0.63%
  • CINGW N/A
  • EPS Growth
  • TECH N/A
  • CINGW N/A
  • EPS
  • TECH 0.98
  • CINGW N/A
  • Revenue
  • TECH $1,196,016,000.00
  • CINGW N/A
  • Revenue This Year
  • TECH $8.19
  • CINGW N/A
  • Revenue Next Year
  • TECH $8.85
  • CINGW N/A
  • P/E Ratio
  • TECH $49.09
  • CINGW N/A
  • Revenue Growth
  • TECH 4.46
  • CINGW N/A
  • 52 Week Low
  • TECH $46.44
  • CINGW N/A
  • 52 Week High
  • TECH $85.57
  • CINGW N/A
  • Technical
  • Relative Strength Index (RSI)
  • TECH 33.97
  • CINGW N/A
  • Support Level
  • TECH $46.44
  • CINGW N/A
  • Resistance Level
  • TECH $53.00
  • CINGW N/A
  • Average True Range (ATR)
  • TECH 3.30
  • CINGW 0.00
  • MACD
  • TECH -0.27
  • CINGW 0.00
  • Stochastic Oscillator
  • TECH 13.00
  • CINGW 0.00

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: